China Factory Supply 99% Purity CAS 16679-58-6 Desmopressin CAS NO.16679-58-6
- FOB Price: USD: 0.02-0.03 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
Top(1-1000)GramTop(1000-2000)Gram
- Product Details
Keywords
- Desmopressin
- CAS 16679-58-6
- Desmopressin 99%
Quick Details
- ProName: China Factory Supply 99% Purity CAS 16...
- CasNo: 16679-58-6
- Molecular Formula: C46H64N14O12S2
- Appearance: White powder
- Application: (1) Treatment of central diabetes insi...
- DeliveryTime: 3-7days
- PackAge: bag or barrel or drum
- Port: Shanghai or Shenzhen or Qingdao
- ProductionCapacity: 6000 Metric Ton/Day
- Purity: 99%+
- Storage: Store at room temperature
- Transportation: by express or air or sea
- LimitNum: 1 Gram
- Moisture Content: <0.001%
- Impurity: <0.001%
- Assay: 99%+
- Shelf Life: 2 years
- Appearance: White Powder
Superiority
English name: Desmopressin
CAS number: 16679-58-6
Molecular formula: C46H64N14O12S2
Molecular weight: 1069.22
EINECS Number: 240-726-7
Specific rotation: D25+85.5±2°(calculated for the free peptide)
Density: 1.56±0.1g/cm3(Predicted)
RTECS No.: YW9000000
Storage conditions:Store at 0°C
Solubility:H2O:soluble20mg/mL,clear,colorless
Form: neat
Acidity coefficient: (pKa) 9.90±0.15 (Predicted)
Desmopressin can increase the activity of coagulation factor VIII in plasma and increase the content of vonWillebrand factor antigen. For patients with mild or moderate factor VIII deficiency and type I von Willebrand disease, factor VIII : C is at least 5% of the normal value, may have short-term hemostatic effect. This drug can control mild bleeding episodes (eg, hemoarthrosis, mucosal bleeding, bleeding after tooth extraction), and can also maintain normal coagulation after some major surgery. Before deciding to use desmopressin rather than blood products, the efficacy of the drug and the duration of efficacy should be tested in patients. Desmopressin is not effective in patients with severe factor VIII deficiency, von Willebrand disease III, or factor IX deficiency. Desmopressin has variable efficacy in von Willebrand disease IIA, but should not be used in patients with von Willebrand disease IIB or platelets. Desmopressin may have a transient effect in patients with uremic bleeding who require urgent action. Uremic patients have abnormal platelet-vessel wall interactions, and the effect of desmopressin is thought to be to release vWF polymer stored in endothelial cells outward, increasing catecholamines, which are mediators of hemostatic function, in plasma. concentration. Desmopressin can also temporarily correct abnormal hemostatic function in patients with chronic liver disease or platelet function deficiency. Desmopressin, given before cardiopulmonary bypass, can reduce intraoperative blood loss, and some observational investigators have found that the drug reduces overall blood loss and the need for transfusions. The susceptibility to bleeding in these patients is due to acquired platelet dysfunction. Desmopressin can also reduce intraoperative blood loss and blood transfusion requirements in spinal fusion patients with normal hemostatic function. The drug will be widely used in blood donors to increase factor VIII activity and improve complementary therapy for hemophilia. Desmopressin has the great advantage in all patients that it avoids the risk of hepatitis and HIV infection due to blood products.
(1) Treatment of central diabetes insipidus. After the drug can reduce urinary excretion, reduce urinary frequency and reduce nocturia.
(2) Treatment of nocturnal enuresis (patients aged 5 years or older).
(3) Test the renal urine concentration function, and carry out the differential diagnosis of renal function.
(4) For hemophilia and other bleeding diseases, this product can shorten the bleeding time and prevent bleeding. It can reduce the amount of intraoperative blood loss and postoperative oozing; especially in conjunction with reasonably controlled blood pressure during surgery, it can reduce intraoperative bleeding from different mechanisms, and reduce postoperative oozing, which can play a better role in blood protection.
Details
Wuhan Kanal Technology Co., Ltd. founded in 2010,it is a large manufacturer of fine Pharmaceutical& Chemical & Cosmetic materials that integrates R&D, production and sales together. Our Kanal company is established under the support of the Wuhan city government, so Kanal has large advantages in enterprise credit, finance security, product quality control, and cargo export.Kanal locates in the national new materials industry park of Wuhan city and is awarded the title of high-tech corporation.
Wuhan Kanal has its own R&D and development laboratory. We Kanal set up a R&D team with rich experience and strong technical strength, most of the practitioners have more than ten years' experience and technology in organic synthesis development. It owns almost 15 acre and more than 280 workers.
An ISO 9001 & GMP qualified company, we are mainly specialized in producing high quality but low price Pharmaceutical intermediates, APIs and other fine chemicals & cosmetics products which related to human and animals medicines as well as additives in gas &oil field, almost half of the goods are for exporting. What's more, we provide the OEM (customize) manufactures, if you can't find materials from the world, then tell us, we will research and produce in our high-tech equipmented laboratory. We are dedicated to satisfying our customers with our products and services.
1. We has 11 years' exporting experience in active pharmaceutical ingredient products.
Our professional and thoughtful after-sales service eliminates your worries.
2.We can provide you with ten thousands of products of different levels.
3. We offer convenient one-station purchasing service.
(1)Any inquiries will be replied within 12 hours.
(2)Dedication to quality, supply & service.
(3)Strictly on selecting raw materials.
(4)Reasonable & competitive price, fast lead time.
Our company is based on the optical valley biological city,making full use of the park policy advantages, focusing on the research and development of biological medicine.
The pharmaceutical intermediates are mainly applied to anti-cancer, anti-depression, cardiovascular, diabetes and other new medicine. The chemical intermediates mainly refer to heterocyclics and OLED intermediates.Our factory produce new fine chemical materials which are mainly used in water treatment, bactericidal and anti-corrosion, dyes, electronic materials and other industry fields.
Wuhan Kanal has export & import license, and hazard chemical sales license. The products are exported to America, Brazil, South Korea, Japan, Taiwan, Malaysia, Thailand, Indonesia, Europe union and other countries or regions.
Under rich experiences and excellent international reputation, the company becomes a quite influential enterprise in China's API field. Wuhan Kanal sincerely look forward to establishing long good cooperation with our customers from all over the world.